Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans.
Guo. Yi-Jie YJ; Zhang. Bo B; Feng. Xue-Song XS; Ren. Hui-Xun HX; Xu. Ji-Ru JR
Key Findings
- EGCG at 0.2 mg/mL kills 100 % of free‑floating S. mutans in 5 h and blocks biofilm formation within 24 h
- LL‑37 alone doesn’t kill the bacteria but boosts EGCG’s ability to prevent and break down biofilms
- LL‑37 binds to EGCG and helps EGCG attach to the bacterial surface molecule LTA, enhancing its antibiofilm action
Practical Outcomes
- Regular green‑tea extracts (EGCG) may help reduce dental plaque, but the added benefit of LL‑37 requires a peptide that isn’t currently sold as a consumer product. Future mouthwashes or toothpaste could incorporate both for stronger anti‑plaque effects, but for now the main actionable tip is to use EGCG‑rich products as part of oral hygiene.
Summary
The study found that the natural compound EGCG from green tea can kill mouth bacteria and stop them from forming sticky biofilms, and that a human peptide called LL‑37 makes EGCG work even better against these biofilms. While EGCG is easy to get, LL‑37 isn’t a common supplement, so the combo isn’t ready for DIY use yet, but it points to possible future oral‑care products that mix the two.
Abstract
Streptococcus mutans forms biofilms as a resistance mechanism against antimicrobial agents in the human oral cavity. We recently showed that human cathelicidin LL-37 exhibits inhibitory effects on biofilm formation of S. mutans through interaction with lipoteichoic acid (LTA), but without antibacterial or biofilm dispersal abilities. (-)-Epigallocatechin gallate (EGCG) is the most abundant constituent of tea catechins that has the greatest anti-infective potential to inhibit the growth of various microorganisms and biofilm formation. Therefore, in this study, we evaluated whether LL-37 interacts with EGCG to enhance the antibiofilm effect of EGCG on S. mutans biofilm formation. Clinical S. mutans strains (n = 10) isolated from children's saliva were tested in a biofilm formation assay. The antibiofilm effect of EGCG with and without LL-37 was analyzed by the minimum biofilm eradication concentration assay and confirmed using field emission-scanning electron microscopy. In addition, the interaction among EGCG, LL-37, and LTA of S. mutans was determined using quartz crystal microbalance analysis. EGCG killed 100 % of planktonic S. mutans within 5 h, inhibited biofilm formation within 24 h, and reduced bacteria cells in preformed biofilms within 3 h at a concentration of 0.2 mg/mL. However, EGCG did not appear to interact with LTA. LL-37 effectively enhanced the bactericidal activity of EGCG against biofilm formation and preformed biofilms as determined by quantitative crystal violet staining and field emission-scanning electron microscopy. In addition, quartz crystal microbalance analysis revealed that LL-37 interacted with EGCG and promoted binding between EGCG and LTA of S. mutans. We show that LL-37 enhances the antibiofilm effect of EGCG on S. mutans. This finding provides new knowledge for dental treatment by using LL-37 as a potential antibiofilm compound.
Study Information
pubmed
2016
2016-09-22T00:00:00.000Z
10.1186/s12903-016-0292-y
8
39